Royce & Associates’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-37,500	Closed	-$3.13M	–	876
2024 Q4	$3.13M	Hold	37,500	–	–	0.03%	558
2024 Q3	$2.74M	Hold	37,500	–	–	0.02%	579
2024 Q2	$2.57M	Buy	37,500 +15,000	+67%	+$1.04M	0.02%	588
2024 Q1	$1.56M	Buy	+22,500	New	+$1.55M	0.01%	665
2018 Q2	–	Sell	-30,000	Closed	-$632K	–	1264
2018 Q1	$632K	Hold	30,000	–	–	﹤0.01%	1028
2017 Q4	$434K	Hold	30,000	–	–	﹤0.01%	1050
2017 Q3	$473K	Hold	30,000	–	–	﹤0.01%	1027
2017 Q2	$373K	Hold	30,000	–	–	﹤0.01%	1052
2017 Q1	$488K	Hold	30,000	–	–	﹤0.01%	1043
2016 Q4	$453K	Buy	30,000 +22,300	+290%	+$315K	﹤0.01%	1015
2016 Q3	$117K	Hold	7,700	–	–	﹤0.01%	1060
2016 Q2	$299K	Buy	+7,700	New	+$277K	﹤0.01%	1027